Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer - a multicentre observational study.
Khadhouri S, Gallagher KM, MacKenzie KR, Shah TT, Gao C, Moore S, Zimmermann EF, Edison E, Jefferies M, Nambiar A, Mannas MP, Lee T, Marra G, Lillaz B, Gómez Rivas J, Olivier J, Assmus MA, Uçar T, Claps F, Boltri M, Burnhope T, Nkwam N, Tanasescu G, Boxall NE, Downey AP, Lal AA, Antón-Juanilla M, Clarke H, Lau DHW, Gillams K, Crockett M, Nielsen M, Takwoingi Y, Chuchu N, O'Rourke J, MacLennan G, McGrath JS, Kasivisvanathan V; IDENTIFY Study group. Khadhouri S, et al. Among authors: shah tt. BJU Int. 2021 Oct;128(4):440-450. doi: 10.1111/bju.15483. Epub 2021 Sep 8. BJU Int. 2021. PMID: 33991045 Free article.
Technological aspects of delivering cryotherapy for prostate cancer.
Lau B, Shah TT, Valerio M, Hamid S, Ahmed HU, Arya M. Lau B, et al. Among authors: shah tt. Expert Rev Med Devices. 2015 Mar;12(2):183-90. doi: 10.1586/17434440.2015.990377. Epub 2015 Jan 8. Expert Rev Med Devices. 2015. PMID: 25569713 Review.
[Focal therapy for prostate cancer: German version].
Kasivisvanathan V, Shah TT, Donaldson I, Kanthabalan A, Moore CM, Emberton M, Ahmed HU. Kasivisvanathan V, et al. Among authors: shah tt. Urologe A. 2015 Feb;54(2):202-9. doi: 10.1007/s00120-014-3668-0. Urologe A. 2015. PMID: 25690574 Review. German.
Multivariable model development and internal validation for prostate cancer specific survival and overall survival after whole-gland salvage Iodine-125 prostate brachytherapy.
Peters M, van der Voort van Zyp JR, Moerland MA, Hoekstra CJ, van de Pol S, Westendorp H, Maenhout M, Kattevilder R, Verkooijen HM, van Rossum PS, Ahmed HU, Shah TT, Emberton M, van Vulpen M. Peters M, et al. Among authors: shah tt. Radiother Oncol. 2016 Apr;119(1):104-10. doi: 10.1016/j.radonc.2016.02.002. Epub 2016 Feb 17. Radiother Oncol. 2016. PMID: 26897512 Free article.
PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure.
Shah TT, Peters M, Kanthabalan A, McCartan N, Fatola Y, van der Voort van Zyp J, van Vulpen M, Freeman A, Moore CM, Arya M, Emberton M, Ahmed HU. Shah TT, et al. Prostate Cancer Prostatic Dis. 2016 Sep;19(3):311-6. doi: 10.1038/pcan.2016.23. Epub 2016 Jul 19. Prostate Cancer Prostatic Dis. 2016. PMID: 27431499 Free PMC article.
Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient prognoses.
Peters M, Kanthabalan A, Shah TT, McCartan N, Moore CM, Arya M, van der Voort van Zyp JR, Moerland MA, Hindley RG, Emberton M, Ahmed HU. Peters M, et al. Among authors: shah tt. Urol Oncol. 2018 Jan;36(1):13.e1-13.e10. doi: 10.1016/j.urolonc.2017.08.022. Epub 2017 Sep 18. Urol Oncol. 2018. PMID: 28927782 Free article.
90 results